As of October 2024, Remedent has a market cap of $1.20M. This makes Remedent the world's 36626th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $799.84K | -60.00% |
2023 | $2.00M | -41.76% |
2022 | $3.43M | 1.00% |
2021 | $3.40M | 13.33% |
2020 | $3.00M | -11.76% |
2019 | $3.40M | -26.09% |
2018 | $4.60M | -32.35% |
2017 | $6.80M | 100.00% |
2016 | $3.40M | 13.33% |
2015 | $3.00M | -55.88% |
2014 | $6.80M | 88.89% |
2013 | $3.60M | 80.00% |
2012 | $2.00M | -44.44% |
2011 | $3.60M | -64.00% |
2010 | $10.00M | 28.21% |
2009 | $7.80M | -44.29% |
2008 | $14.00M | -54.84% |
2007 | $30.99M | 2.65% |
2006 | $30.19M | - |